SCHEMBL6289261

SCHEMBL6289261

C=CCC1CCC(CC=C)O1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 2/20 0.31
CTRC Q99895 2/20 0.31
F2 P00734 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17930128 0.88 PRSS1 (0.31) PRSS1CTRCF2
SCHEMBL2107956 0.85 ALDH1A1 (0.32) ALDH1A1TDP1
SCHEMBL11382499 0.83
SCHEMBL12658144 0.83
SCHEMBL8704531 0.79 PRSS1 (0.33) PRSS1CTRCF2
SCHEMBL8704527 0.79 PRSS1 (0.33) PRSS1CTRCF2
SCHEMBL8704532 0.79 PRSS1 (0.33) PRSS1CTRCF2
SCHEMBL12714094 0.79 PTGES2 (0.31)
SCHEMBL24797534 0.76 PRSS1 (0.34) PRSS1CTRCF2
SCHEMBL1613607 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6599996-B1 Transition-metal-catalyzed preparation of polymers having a syndiotactic or predominantly syndiotactic structure from vinylaromatic monomers and a process for preparing block copolymers from vinylaromatic monomers and olefin polymer BASF AKTIENGESELLSCHAFT (DE) 2003-07-29 US claimed
EP-0980873-B1 Binuclear metal hydride complexes and their use as catalysts for the (co)polymerization of polar monomers BASF AG (DE) 2002-11-27 EP claimed
EP-1237942-A1 METHOD FOR (CO)POLYMERIZING POLAR AND NON-POLAR MONOMERS BASF AKTIENGESELLSCHAFT (DE) 2002-09-11 EP claimed
US-6291655-B1 CONTAINING YTTRIUM; FOR POLYMERIZATION OF ETHYLENE BASF AKTIENGESELLSCHAFT (DE) 2001-09-18 US claimed
WO-2001042314-A1 METHOD FOR (CO)POLYMERIZING POLAR AND NON-POLAR MONOMERS BASF AKTIENGESELLSCHAFT (DE) 2001-06-14 WO claimed
EP-0980873-A2 Binuclear metal hydride complexes and their use as catalysts for the (co)polymerization of polar monomers BASF AKTIENGESELLSCHAFT (DE) 2000-02-23 EP claimed
WO-2005121160-A2 11, 12 CYCLIC THIOCARBAMATE MACROLIDE ANTIBACTERIAL AGENTS JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT (US) 2005-12-22 WO disclosed
US-20050250713-A1 11,12-Cyclic thiocarbamate macrolide antibacterial agents ZHU BIN 2005-11-10 US disclosed
US-6599996-B1 Transition-metal-catalyzed preparation of polymers having a syndiotactic or predominantly syndiotactic structure from vinylaromatic monomers and a process for preparing block copolymers from vinylaromatic monomers and olefin polymer BASF AKTIENGESELLSCHAFT (DE) 2003-07-29 US disclosed
EP-0980873-B1 Binuclear metal hydride complexes and their use as catalysts for the (co)polymerization of polar monomers BASF AG (DE) 2002-11-27 EP disclosed
EP-1237942-A1 METHOD FOR (CO)POLYMERIZING POLAR AND NON-POLAR MONOMERS BASF AKTIENGESELLSCHAFT (DE) 2002-09-11 EP disclosed
US-6291655-B1 CONTAINING YTTRIUM; FOR POLYMERIZATION OF ETHYLENE BASF AKTIENGESELLSCHAFT (DE) 2001-09-18 US disclosed
WO-2001042314-A1 METHOD FOR (CO)POLYMERIZING POLAR AND NON-POLAR MONOMERS BASF AKTIENGESELLSCHAFT (DE) 2001-06-14 WO disclosed
EP-0980875-A2 Polymerisation-active not bridged mononuclear bis alkylmetal-half-sandwich complexes based on rare earth metals BASF AKTIENGESELLSCHAFT (DE) 2000-02-23 EP disclosed
EP-0980873-A2 Binuclear metal hydride complexes and their use as catalysts for the (co)polymerization of polar monomers BASF AKTIENGESELLSCHAFT (DE) 2000-02-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250713-A1 11,12-Cyclic thiocarbamate macrolide antibacterial agents MRPL21, TTC14, MRPL12 PRSS1 3155/4885CTRC 528/4885F2 4827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.